CD109 and systemic sclerosis: Knockdown of CD109 in skin fibroblasts from non-SSc and SSc individuals resulted in evidence of TGFβ signaling activation, including Smad2/3 phosphorylation and increased ECM protein expression, whereas CD109 gain-of-function reduced ECM protein expression.